Search

Health Canada Clears Cynosure Lutronic XERF for Skin Tightening

Health Canada has cleared Cynosure Lutronic’s XERF, a radiofrequency (RF) skin-tightening device.

XERF’s multi-frequency monopolar RF technology combines 6.78 MHz and 2 MHz frequencies, enabling providers to precisely deliver energy at multiple tissue depths, effectively heating the fibrous septae to generate both immediate and lasting skin-tightening results.

XERF’s Wave Fit pulse and Advanced Integrated Cryogen Delivery (ICD) Cooling technologies work in tandem to regulate energy delivery and maintain optimal surface temperature for comfortable treatment experience without the need for numbing.

The device’s Spider Pattern Tip is designed to reduce skin-edge effects. This tip ensures a controlled treatment environment, increasing treatment efficacy and patient safety.

An Exciting Milestone

“The clearance of XERF in Canada marks an exciting milestone for Cynosure Lutronic as we expand our presence in North America,” says Lowinn Kibbey, President, North America at Cynosure Lutronic, in a news release. “As patients continue to seek effective treatments to tighten and revitalize their skin, they often face challenges with discomfort or downtime. With XERF, we are thrilled to offer a solution that delivers exceptional results while providing a more comfortable experience. This breakthrough allows both patients and providers to achieve their desired outcomes with greater ease and confidence.”

“As a fellowship-trained cosmetic dermatologist, we prioritize treatments in our clinic that can consistently deliver results with minimal risk and downtime. XERF incorporates the newest technology to safely deliver energy deep into the skin, while offering intelligent cooling for superior protection and patient comfort,” adds Jordan V. Wang, MD, MBE, MBA, who is the Medical Director of Laser & Skin Surgery Center of Pennsylvania and Medical Research Director at the office of Roy Geronemus, MD.

XERF launched in 2024 and is currently sold in Korea, Japan, and Hong Kong. With its Health Canada clearance, Cynosure Lutronic is prioritizing Canada as its first North American launch market.